Aspirin-tolerant asthmatics generate more lipoxins than aspirin- intolerant asthmatics

European Respiratory Journal

Volumn 16, Issue 1, 2000, Pages 44-49

  Sanak, M ^a   Levy, B D ^b   Clish, C B ^b   Chiang, N ^b   Gronert, K ^b   Mastalerz, L ^a   Serhan, C N ^b   Szczeklik, A ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Anti inflammatory mediators; Aspirin intolerant asthma; Cysteinyl leukotrienes; Lipoxins

Indexed keywords

ACETYLSALICYLIC ACID; BRONCHOCONSTRICTING AGENT; CALCIMYCIN; INTERLEUKIN 3; IONOPHORE; LIPOXIN;

ADULT; ARTICLE; ASTHMA; DRUG TOLERANCE; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; FEMALE; HUMAN; MALE; MEDIATOR; PRIORITY JOURNAL;

ADULT; ASPIRIN; ASTHMA; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; LEUKOTRIENE C4; LIPOXINS; MALE; MIDDLE AGED; STEREOISOMERISM;

EID: 0033924902     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3003.2000.16a08.x     Document Type: Article

References (29)

1. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999; 104: 5-13.
2. Samter M, Beers RF Jr. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968; 68: 975-983.
3. 4, and histamine in asthmatics. Am Rev Respir Dis 1992; 146: 96-103.
4. Ortolani C, Mirone C, Fontana A, et al. Study of mediators of anaphylaxis in nasal wash fluids after aspirin and sodium metabisulfite nasal provocation in intolerant rhinitic patients. Ann Allergy 1987; 59: 106-112.
5. Kowalski ML, Sliwinska-Kowalska M, Igarashi Y, et al. Nasal secretions in response to acetylsalicylic acid. J Allergy Clin Immunol 1993; 91: 580-598.
6. Samuelsson B, Dahlen SE, Lindgren JA, Rouzer CA, Serhan CN. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 1987; 237: 1171-1176.
7. Drazen JM, Israel E, O'Byrne PM. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999; 340: 197-206.
8. Nasser SM, Pfister R, Christie PE, et al. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Am J Respir Crit Care Med 1996; 153: 90-96.
9. 4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998; 101: 834-846.
10. Israel E, Fischer AR, Rosenberg MA, et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis 1993; 148: 1447-1451.
11. Dahlen B, Nizankowska E, Szczeklik A, et al. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med 1998; 157: 1187-1194.
12. Serhan CN, Haeggstrom JZ, Leslie CC. Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J 1996; 10: 1147-1158.
13. 4 on airway responses in asthmatic subjects. Am Rev Respir Dis 1992; 145: 1281-1284.
14. Serhan CN. Lipoxins and novel aspirin-triggered 15-epilipoxins (ATL): a jungle of cell-cell interactions ora therapeutic opportunity? Prostaglandins 1997; 53: 107-137.
15. 4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. Am Rev Respir Dis 1990; 141: 1453-1458.
16. 4-ELISA. Lipids 1993; 28: 1047-1053.
17. Edenius C, Kumlin M, Bjork T, Anggard A, Lindgren JA. Lipoxin formation in human nasal polyps and bronchial tissue. FEBS Lett 1990; 272: 25-28.
18. 4: structure-function relationships. Biochem Biophys Res Commun 1991; 180: 1416-1421.
19. 4 and granulocytic infiltration into asthmatic airways. Lancet 1993; 341: 989-990.
20. Clària J, Serhan CN. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 1995; 92: 9475-9479.
21. 4 stable analogs are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors. J Exp Med 1997; 185: 1693-1704.
22. Szczeklik A, Sladek K, Dworski R, et al. Bronchial aspirin challenge causes specific eicosanoid response in aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1996; 154: 1608-1614.
23. 4 ELISA. J Pharmacol Exp Ther 1998; 287: 779-790.
24. 2 production. Inflamm Res 1996; 45: 246-253.
25. Levy BD, Gronert K, Clish C, Serhan CN. Leukotriene and lipoxin biosynthesis. In: Laychock S, Rubin RP, eds. Lipid second messengers. Methods in signal transduction. Boca Raton, FL, USA, CRC Press LLC, 1999; pp. 83-111.
26. 4 release. J Allergy Clin Immunol 1998; 102: 512-520.
27. Picado C, Fernandez-Morata JC, Juan M, et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med 1999; 160: 291-296.
28. Gavett SH, Madison SL, Chulada PC, et al. Allergic lung responses are increased in prostaglandin H synthase-deficient mice. J Clin invest 1999; 104: 721-732.
29. Dahlén S-E, Serhan CN. Lipoxins: bioactive lipoxygenase interaction products. In: Wong A, Crooke ST, eds. Lipoxygenases and their products. San Diego, CA, USA, Academic Press, 1991; pp. 235-276.